Op-T-Mune, Inc
Denver, United States · Founded 2017 · $300K raised
- Headquarters
- Denver, Colorado
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2G
- Website
- op-t-muneinc.com
- Total Funding
- $300K
- Last Round
- $300K GrantJan 2012
- Rounds
- 2
About
Op-T-Mune was founded to commercialize the intellectual property of Dr. David Wagner at the University of Colorado Denver. The company develops treatments and diagnostics for autoimmune diseases including type 1 diabetes and multiple sclerosis, focusing on controlling CD40-mediated autoimmune inflammation and identifying pathogenic cells as diagnostic tools.
Summary
Op-T-Mune, Inc is a Biotech company based in Denver, United States, founded in 2017. It has raised $300K in total across 2 rounds, most recently a $300K Grant round in Jan 2012. Investors include NIH NIAID and National Institutes of Health.
Funding History
Jan 2012
Sign up to see all 2 rounds
Grant — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/op-t-mune-inc"><img src="https://indexed.vc/api/badge/company/op-t-mune-inc" alt="Op-T-Mune, Inc on Indexed.vc" width="260" height="76" /></a>